Skip to main content
VCbacked
Log inGet Started

Sensible Biotechnologies

Cambridge, United States

Sensible Biotechnologies is developing world's first cell-based platform to unlock the next generation of mRNA medicines.

$4.2M raised
Apr 2023
Pre-Seed
BiotechnologyMedical

Top Investors

Y CombinatorBlueYard CapitalCivilization VenturesZAKA VCPossible Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sensible Biotechnologies

How much funding has Sensible Biotechnologies raised?
Sensible Biotechnologies has raised $4.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.
Who are Sensible Biotechnologies's investors?
Sensible Biotechnologies's investors include Y Combinator, BlueYard Capital, Civilization Ventures, ZAKA VC, Possible Ventures.
Where is Sensible Biotechnologies headquartered?
Sensible Biotechnologies is headquartered in Cambridge, United States.
What does Sensible Biotechnologies do?
Sensible Biotechnologies is developing world's first cell-based platform to unlock the next generation of mRNA medicines.
What stage is Sensible Biotechnologies at?
Sensible Biotechnologies is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sensible Biotechnologies — Funding & Investors." VCBacked, April 6, 2023, https://www.vcbacked.co/company/sensible-biotechnologies. Accessed June 3, 2026.
APA
VCBacked. (2023). Sensible Biotechnologies — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/sensible-biotechnologies
Wikipedia (cite web)
{{cite web |title=Sensible Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/sensible-biotechnologies |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong